Inventor
MARC LABELLE
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes15%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
C07DHeterocyclic compounds12%
Y02ATechnologies for adaptation to climate change12%
G01MTesting static or dynamic balance of machines or structures8%
G06NComputing arrangements based on specific computational models8%
G07CTime or attendance registers8%
G10LSpeech analysis techniques or speech synthesis8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07HSugars4%
PatentTitleYear
12,046,254Multi-sensor devices and systems for evaluating vehicle conditions202412,012,393Oxopiperazine derivatives202411,783,851Multi-sensor devices and systems for evaluating vehicle conditions202311,730,714Compounds for the treatment of neuromuscular disorders202311,560,399Process for preparing mannose derivatives202311,306,068Oxopiperazine derivatives202211,147,788Compounds for the treatment of neuromuscular disorders2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2023Patents assigned to NMD PHARMA AS (2)· patent assignee history
2021–2024Based in US· patent location history
2022–2024Patents assigned to Inthera Bioscience AG (2)· patent assignee history
2023–2024Patents assigned to ACV AUCTIONS INC (2)· patent assignee history
2023Patents assigned to ENTEROME (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ACV AUCTIONS INC | 2 | 2023–2024 |
| Inthera Bioscience AG | 2 | 2022–2024 |
| NMD PHARMA AS | 2 | 2021–2023 |
| ENTEROME | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2021–2024 |